StreetAlpha
Lineage Cell Therapeutics, Inc. · SEC Form 4

LCTX Insider Trading

From SEC Form 411 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of Lineage Cell Therapeutics, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $895K bought and $0 sold.

← LCTX stock page

Insiders are buying
Bought, 12 months$895K6 buys · 5 insiders
Sold, 12 months$00 sales · 0 insiders
Net+$895Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
DecJanFeb2026-03: bought $24KMarAprMayJunJulAugSepOct2026-11: bought $871KNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when LCTX insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an LCTX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

LCTX cluster buys

All LCTX cluster buys →
  • 5 insiders bought $871KTrades Nov 16, 2026 to Nov 17, 2026 · public Nov 17, 2026

A cluster buy is two or more insiders buying on the open market within 30 days of each other.

Every LCTX insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Nov 17, 2026Broadwood Partners, L.P.DirectorBuy1,000,000$0.77$771K50,560,992Nov 19Form 4
Nov 17, 2026Michael H. MulroyDirectorBuy30,000$0.87$26K328,555Nov 19Form 4
Nov 16, 2026Brian M CulleyPresident and CEOBuy40,500$0.92$37K296,016Nov 17Form 4
Nov 16, 2026Deborah J AndrewsDirectorBuy25,000$0.80$20K40,578Nov 17Form 4
Nov 16, 2026Jill Ann HoweCFOBuy20,000$0.85$17K45,500Nov 16Form 4
Mar 12, 2026Brian M CulleyPresident and CEOBuy15,000$1.63$24K255,516Mar 12Form 4
Jan 27, 2025Broadwood Capital Inc10% ownerBuy7,894,737$0.76$6M49,560,992Jan 28Form 4
Nov 26, 2024George A. Samuel IIIGeneral CounselBuy15,000$0.60$9K22,184Nov 26Form 4
Nov 26, 2024Jill Ann HoweCFOBuy15,000$0.59$9K25,500Nov 26Form 4
Nov 22, 2024Michael H. MulroyDirectorBuy40,000$0.57$23K298,555Nov 25Form 4
Nov 21, 2024Brian M CulleyPresident and CEOBuy40,000$0.60$24K194,842Nov 22Form 4

LCTX insider trading FAQ

Are LCTX insiders buying or selling?

Insiders are buying over the last 12 months. 5 insiders bought $895K of LCTX on the open market in 6 trades, and 0 sold $0 in 0 trades.

When did an LCTX insider last buy shares?

Broadwood Partners, L.P. (Director) bought 1,000,000 shares for $771K on Nov 17, 2026, reported on Nov 19, 2026.

When did an LCTX insider last sell shares?

There has been no open market insider sale of LCTX in the last two years.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice